Tiziana Life Sciences

$3.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.01%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TLSA and other stocks, options, and ETFs commission-free!

About TLSA

Tiziana Life Sciences plc American Depository Share, also called Tiziana Life Sciences, is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. The listed name for TLSA is Tiziana Life Sciences plc American Depository Share.

CEO
Kunwar Shailubhai
Employees
10
Headquarters
London, Greater London
Founded
2013
Market Cap
271.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
544.81K
High Today
$3.13
Low Today
$2.82
Open Price
$2.98
Volume
520.52K
52 Week High
$12.17
52 Week Low
$0.6226

TLSA Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, Pre-Market

You May Also Like

ASAN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure